Anti-BCL9 transcription coactivator antibodies are directed against the protein encoded by the gene BCL9 in humans. The gene may also be known as B cell CLL/lymphoma 9, LGS, B-cell CLL/lymphoma 9 protein, and B-cell lymphoma 9 protein. Structurally, the protein is reported to be 149.3 kilodaltons in mass. Based on gene name, canine, porcine, monkey, mouse and rat orthologs may also be found.
Click on the product pages below for more detailed antibody information including target specificity, validated applications and product-specific citations.